These success, together with a previous report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the thought of concentrating on ACKR3 as a novel solution to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked disorders.Gene expression analysis uncovered that ACK